Merck : MRK

All Merck Articles

1083 Articles

Jon C. Ogg | Sep 29, 2014 at 4:05 PM EDT

The Best- and Worst-Performing DJIA Stocks in 2014

The bull market may be five and a half years old, but stocks have been fighting each week to hit…

Jon C. Ogg | Sep 25, 2014 at 9:50 AM EDT

Short Sellers Run for Cover in Defensive High-Yield Dividend Stocks

24/7 Wall St. takes look at what is happening in the short interest of the go-to high-dividend defensive stocks.

Jon C. Ogg | Sep 24, 2014 at 6:45 AM EDT

The Best Performing DJIA Stocks of 2014

The bull market may be five and a half years old, but stocks have been fighting each week to hit…

Lee Jackson | Sep 18, 2014 at 8:15 AM EDT

Credit Suisse Gold Standard Yield Stocks May Be the Safest to Own Now

Here are the four "Gold Standard" stocks from Credit Suisse that offer a combination of a higher yield and more…

Lee Jackson | Sep 15, 2014 at 10:55 AM EDT

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

A new research report from UBS focuses on four top companies that are making great strides in treatments for patients…

Paul Ausick | Sep 12, 2014 at 4:01 PM EDT

The 4 Stocks That Tanked the Market

thinkstockSeptember 12, 2014: Markets opened lower on Friday as the energy sector and utilities opened weaker. The stronger dollar weakens…

Jon C. Ogg | Sep 11, 2014 at 9:05 AM EDT

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

The short interest data for the August 29 settlement date is out, and we have decided to look at what…

Paul Ausick | Sep 5, 2014 at 4:01 PM EDT

The 4 Stocks That Lifted the Market

thinkstockSeptember 5, 2014: Markets opened lower on Friday following a disappointing report on employment that investors later took as a…

Jon C. Ogg | Sep 4, 2014 at 4:45 PM EDT

What This Skin Cancer Drug Approval Really Means to Merck

Merck & Co. has received approval from the FDA to bring its new drug Keytruda to market.

Paul Ausick | Sep 3, 2014 at 4:01 PM EDT

The 4 Stocks That Steered the Market

thinkstockSeptember 3, 2014: Markets opened higher on Wednesday following a report — later said to be inaccurate — of a…

Lee Jackson | Sep 2, 2014 at 8:30 AM EDT

Top-Yielding Stocks Dominate UBS Equity Focus List for September

In a new research report from the UBS CIO Wealth Management Research team, they continue to have a very favorable…

Trey Thoelcke | Aug 27, 2014 at 1:00 PM EDT

Short Interest Swings in High-Yield Dividend Stocks

4/7 Wall St. reviews short interest in the higher-yield defensive dividend stocks for a sense of what short sellers may…

Paul Ausick | Aug 25, 2014 at 4:01 PM EDT

The 4 Stocks That Helped Lift the S&P Above 2,000

thinkstockAugust 25, 2014: Markets opened higher on Monday, and the S&P pushed above the 2,000 mark for the first time…

Paul Ausick | Aug 14, 2014 at 4:01 PM EDT

The 4 Stocks That Carried the Market

thinkstockAugust 14, 2014: Markets opened higher on Thursday after a slightly worse-than-expected report on new claims for unemployment benefits. U.S.…

Jon C. Ogg | Aug 12, 2014 at 10:42 AM EDT

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

The short interest data is out for the July 31 settlement date. We often review the higher-yield defensive dividend stocks…

1 … 46 47 48 49 50 … 73

Merck : MRK

All Merck Articles

The Best- and Worst-Performing DJIA Stocks in 2014

Short Sellers Run for Cover in Defensive High-Yield Dividend Stocks

The Best Performing DJIA Stocks of 2014

Credit Suisse Gold Standard Yield Stocks May Be the Safest to Own Now

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

The 4 Stocks That Tanked the Market

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

The 4 Stocks That Lifted the Market

What This Skin Cancer Drug Approval Really Means to Merck

The 4 Stocks That Steered the Market

Top-Yielding Stocks Dominate UBS Equity Focus List for September

Short Interest Swings in High-Yield Dividend Stocks

The 4 Stocks That Helped Lift the S&P Above 2,000

The 4 Stocks That Carried the Market

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

Want $1,500 a Month in Rent Without a Single 2 a.m. Phone Call? These 3 ETFs Pay You Like a Landlord

Why a $50,000 401(k) Loan at 50 Could Quietly Cost You $100,000 by Retirement

Inflation Subtly Stole 20% of Your Savings Since 2020. These 3 ETFs Hit Back

Why a $50,000 401(k) Loan at 50 Could Quietly Cost You $100,000 by Retirement

Her Husband Handled the Medicare Paperwork. After He Died, Her Premium Doubled Overnight.

Want $1,500 a Month in Rent Without a Single 2 a.m. Phone Call? These 3 ETFs Pay You Like a Landlord

Why a $50,000 401(k) Loan at 50 Could Quietly Cost You $100,000 by Retirement

Merck : MRK

All Merck Articles

The Best- and Worst-Performing DJIA Stocks in 2014

Short Sellers Run for Cover in Defensive High-Yield Dividend Stocks

The Best Performing DJIA Stocks of 2014

Credit Suisse Gold Standard Yield Stocks May Be the Safest to Own Now

U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks

The 4 Stocks That Tanked the Market

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

The 4 Stocks That Lifted the Market

What This Skin Cancer Drug Approval Really Means to Merck

The 4 Stocks That Steered the Market

Top-Yielding Stocks Dominate UBS Equity Focus List for September

Short Interest Swings in High-Yield Dividend Stocks

The 4 Stocks That Helped Lift the S&P Above 2,000

The 4 Stocks That Carried the Market

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

Want $1,500 a Month in Rent Without a Single 2 a.m. Phone Call? These 3 ETFs Pay You Like a Landlord

Why a $50,000 401(k) Loan at 50 Could Quietly Cost You $100,000 by Retirement

Inflation Subtly Stole 20% of Your Savings Since 2020. These 3 ETFs Hit Back

Featured Reads

Why a $50,000 401(k) Loan at 50 Could Quietly Cost You $100,000 by Retirement

Her Husband Handled the Medicare Paperwork. After He Died, Her Premium Doubled Overnight.